When it comes to Retatrutide, the TRIUMPH Phase 3 program is evaluating it for chronic weight management, obstructive sleep apnea, knee osteoarthritis, and cardiovascular outcomes, with data continuing to emerge
The honest summary: if fat loss is the clinical goal, GLP-1 receptor agonists are supported by orders of magnitude more human evidence than AOD-9604
Geroscience (2023)
Its usually more diffuse, so youll notice hair loss from everywhere, as opposed to androgenetic alopecia, which may be more of a localized area. If you notice increased hair shedding, Holman suggested taking a quick inventory of your personal history: Are there any new medications, stresses, illnesses, or major body [or] life changes in the last three months? Diet and other lifestyle factors can have serious effects on hair health, so paying attention to what youre eating and general stress level are good places to start
The critical gap: There are no published human clinical trials examining BPC-157 for depression, anxiety, or any psychiatric condition
These peptides are often described in research contexts